The DOI matches its Crossref record; 6 of the 7 references it cites were found in a registry or an index.
Stem Cell Therapy for Heart Failure: An Unfulfilled Promise?
Open accessAbstract
valve replacement in an unselected population: a report from the STS/ACC Transcatheter Valve Therapy Registry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unfortunately, the weight of evidence so far indicates no clinically meaningful benefit resulting from injection therapies, owing to the limited engraftment capacity of the injected CMs and the lack of control over the cells' survival, arrangement, and electromechanical coupling 48 .”
From Leaf-venation-directed cellular alignment for macroscale cardiac constructs with tissue-like functionalities (2023) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000435 · Cited by 906
Halliday, B. P., Wassall, R., Lota, A. S., Khalique, Z., Gregson, J., Newsome, S., Jackson, R. W., Rahneva, T., Wage, R., Smith, G. C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32484-x · Cited by 657
Madonna, R., Laake, L. W. V., Davidson, S. M., Engel, F. B., Hausenloy, D. J., Lecour, S., Leor, J., Perrino, C., Schulz, R., Kirsti Ytrehus, B., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw113 · Cited by 242
Cell-Based Therapy in Cardiac Regeneration
Braunwald, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.313484 · Cited by 84
Heart Failure with Myocardial Recovery - The Patient Whose Heart Failure Has Improved: What Next?
Nijst, P., Martens, P., & Müllens, W. (2017) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2017.05.009 · Cited by 33
Goff, Z. D., Kichura, A. B., Chibnall, J. T., & Hauptman, P. J. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.2988 · Cited by 9
Research works printed but not linked: 1
- Yau, Effect of intramyocardial injection of mesenchymal precursor cells on successful temporary weaning from left ventricular assist device support among patients with advanced heart failure: a randomized clinical trial, JAMA
Cited by
Sorted by citations
Bioengineering approaches to treat the failing heart: from cell biology to 3D printing
Yadid, M., Oved, H., Silberman, E., & Dvir, T. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00603-7 · Cited by 83
Harnessing organs-on-a-chip to model tissue regeneration
Tavakol, D. N., Fleischer, S., & Vunjak‐Novakovic, G. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.05.008 · Cited by 68
Current challenges in three-dimensional bioprinting heart tissues for cardiac surgery
Roche, C. D., Brereton, R. J. L., Ashton, A. W., Jackson, C., & Gentile, C. (2020) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaa093 · Cited by 63
Trials and tribulations of cell therapy for heart failure: an update on ongoing trials
Zhang, J. J., Pogwizd, S. M., Fukuda, K., Zimmermann, W., Fan, C., Hare, J. M., Bolli, R., & Menasché, P. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01098-8 · Cited by 52
Ghanta, R. K., Aghlara-Fotovat, S., Pugazenthi, A., Ryan, C. T., Singh, V., Mathison, M. N., Jarvis, M., Mukherjee, S., Hernández, A., & Omid Veiseh, A. (2020) · Biomaterials Science · doi:10.1039/d0bm00855a · Cited by 47
Metadata
- Authors
- Curfman, G.
- Affiliations
- Deputy Editor, JAMA
- Corresponding author
- Curfman, Gregory
- ORCID
- Curfman, Gregory
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2019-03-26
- Volume
- 321
- Issue
- 12
- Pages
- 1186
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2922678205
- Cited by
- 30
- References
- 7
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 11 · 2020: 3 · 2019: 5
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Keywords
- stem cell therapy, heart failure, cell therapy, regenerative medicine
- MeSH terms
- Heart Failure, Heart-Assist Devices, Humans, Injections, Weaning, Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
